Alleviation of cuproptosis contributes to the reduction of early brain injury by mitophagy after subarachnoid hemorrhage

BACKGROUND: The role of cuproptosis, a novel mitochondrial-dependent cell death, in early brain injury (EBI) after subarachnoid hemorrhage (SAH) remains unknown. We investigated whether cuproptosis drives EBI and how it is regulated by mitophagy. METHODS: Using in vivo and in vitro SAH models, we analyzed cuproptosis markers (DLAT, FDX1), copper transporters (SLC31A1, ATP7B), and the therapeutic effects of copper chelation (tetrathiomolybdate, TTM) and rapamycin-induced mitophagy (verified via chloroquine blockade). RESULTS: SAH induced neuronal cuproptosis-associated features, characterized by SLC31A1/ATP7B-mediated copper overload and pathognomonic DLAT aggregation, while TTM treatment significantly ameliorated EBI. While SAH partially activated endogenous PINK1-Parkin mitophagy, this response was insufficient to halt mitochondrial collapse. Notably, Rapamycin enhanced both canonical (PINK1-Parkin) and non-canonical (Nix, FUNDC1) mitophagy pathways. This dual activation promoted the clearance of toxic DLAT aggregates, alleviated intracellular copper accumulation alongside reduced SLC31A1 expression, and restored mitochondrial membrane potential. Consequently, Rapamycin treatment reduced brain edema and improved neurological scores; however, intercepting mitophagic flux with chloroquine reversed its anti-cuproptotic effects. CONCLUSIONS: Cuproptosis-associated pathology is an important pathological driver of EBI following SAH. Pharmacological enhancement of mitophagic clearance via Rapamycin offers a promising strategy to mitigate neuronal damage at least in part by alleviating copper-induced proteotoxicity.

Authors

Institutions

Publication Details

Journal
Brain Research Bulletin
Published
2026-11-18
DOI
https://doi.org/10.1016/j.brainresbull.2026.112227
Primary Topic
Intracerebral and Subarachnoid Hemorrhage Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Alleviation of cuproptosis contributes to the reduction of early brain injury by mitophagy after subarachnoid hemorrhage

Yirui Kuang, Pengfei Luo, Haonan Fan, Jianmin Zhang et al.
1 links
Brain Research Bulletin
Intracerebral and Subarachnoid Hemorrhage Research
article

Alleviation of cuproptosis contributes to the reduction of early brain injury by mitophagy after subarachnoid hemorrhage

Yirui Kuang, Pengfei Luo, Haonan Fan, Jianmin Zhang, Weilin Xu, Jun Yan, Haocheng Zhang
article en

Abstract

BACKGROUND: The role of cuproptosis, a novel mitochondrial-dependent cell death, in early brain injury (EBI) after subarachnoid hemorrhage (SAH) remains unknown. We investigated whether cuproptosis drives EBI and how it is regulated by mitophagy. METHODS: Using in vivo and in vitro SAH models, we analyzed cuproptosis markers (DLAT, FDX1), copper transporters (SLC31A1, ATP7B), and the therapeutic effects of copper chelation (tetrathiomolybdate, TTM) and rapamycin-induced mitophagy (verified via chloroquine blockade). RESULTS: SAH induced neuronal cuproptosis-associated features, characterized by SLC31A1/ATP7B-mediated copper overload and pathognomonic DLAT aggregation, while TTM treatment significantly ameliorated EBI. While SAH partially activated endogenous PINK1-Parkin mitophagy, this response was insufficient to halt mitochondrial collapse. Notably, Rapamycin enhanced both canonical (PINK1-Parkin) and non-canonical (Nix, FUNDC1) mitophagy pathways. This dual activation promoted the clearance of toxic DLAT aggregates, alleviated intracellular copper accumulation alongside reduced SLC31A1 expression, and restored mitochondrial membrane potential. Consequently, Rapamycin treatment reduced brain edema and improved neurological scores; however, intercepting mitophagic flux with chloroquine reversed its anti-cuproptotic effects. CONCLUSIONS: Cuproptosis-associated pathology is an important pathological driver of EBI following SAH. Pharmacological enhancement of mitophagic clearance via Rapamycin offers a promising strategy to mitigate neuronal damage at least in part by alleviating copper-induced proteotoxicity.

Brain Research BulletinVol. 247
Guangxi Medical University (CN), Tumor Hospital of Guangxi Medical University (CN), Second Affiliated Hospital of Zhejiang University (CN), Zhejiang University (CN)
Good health and well-being
Intracerebral and Subarachnoid Hemorrhage Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon